Roivant Sciences Ltd (ROIV)
Return on assets (ROA)
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -171,981 | 4,348,930 | -1,009,030 | -845,262 | -809,234 |
| Total assets | US$ in thousands | 5,436,940 | 7,222,480 | 2,389,600 | 2,585,130 | 2,689,690 |
| ROA | -3.16% | 60.21% | -42.23% | -32.70% | -30.09% |
March 31, 2025 calculation
ROA = Net income ÷ Total assets
= $-171,981K ÷ $5,436,940K
= -3.16%
The return on assets (ROA) of Roivant Sciences Ltd has fluctuated significantly over the past few years. The ROA was negative in the fiscal years ending March 31, 2021, March 31, 2022, and March 31, 2023, indicating that the company's net income generated from its assets was insufficient or negative during these periods.
However, there was a notable improvement in the fiscal year ending March 31, 2024, with a ROA of 60.21%, suggesting that the company was able to generate a significant profit relative to its assets during that period. This indicates a potential turnaround or increased efficiency in asset utilization.
The data for March 31, 2025, is represented as "—", which may indicate that the information for that period is not available or has not been disclosed.
Overall, the trend in ROA for Roivant Sciences Ltd has been volatile, with negative ROA in the earlier years, followed by a significant positive ROA in the most recent year. It is essential for the company to focus on sustaining or improving this positive trend to ensure efficient utilization of assets and sustained profitability.
Peer comparison
Mar 31, 2025